Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £195.03m
BMD Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead 2vt Share Chart

Interim Management Statement

18 Nov 2011 16:11

Baronsmead VCT 3 plc Interim Management Statement

For the three month period from 1 July 2011 to 30 September 2011.

Headlines-

4.5p second interim dividend declared payable on 9 December 2011 to

shareholders on the register as of 25 November 2011 Sale of investment in Quantix at 3.1 times cost

Performance SummaryCapital return As at As at Movement 30 Sep 2011 30 Jun 2011 Total net assets £62.99m £66.70m Net asset value per share 105.41p 108.43p* (2.8%) Share price 95.25p 96.25p (1.0%) Discount to NAV (9.6%) (11.2%) 3 month (%) 1 year (%) 5 years(%) Since launch (%) Net asset valuetotal return (2.7) 9.9 18.0 91.1(1) Share pricetotal return(2) 2.1 15.7 25.4

73.8

FTSE All-sharetotal return(3) (13.5) (4.4) 4.0 25.6

* Stated after allowing for 3.0p interim dividend for comparative purposes. NAV at 30 June 2011 excluding effect of dividend was 111.43p.

Key:

(1) NAV total return = NAV + reinvested dividends; Source: ISIS EP LLP

(2) Share price total return = Mid to mid share price + reinvested dividends;

Source: AIC

(3) FTSE All-share = FTSE All-share Index + reinvested dividends; Source: AIC

These total returns are stated before the inclusion of VCT taxreliefs which are designed to mitigate the higher risks and costs associatedwith investing in smaller companies and the constraints of the VCT legislation.The tax reliefs given at the time of subscription have been 20%, 40%and later 30%, so any adjusted performance measure including this relief willvary depending on the date of subscription. There is the additional benefit ofreceiving VCT dividends tax free.

Investment Performance

The net asset value total return of the company fell 2.7% during the quartercompared to a drop of 13.5% in the FTSE All Share Total Return over the sameperiod. The unquoted valuation movement stayed flat in the quarter while theAIM portfolio fell by 10.3%.Top ten Investments Position Position Percentage at at of NAV 30 Sep 30 June 2011 as at 30 Sep 2011 2011 Company 1 1 Nexus Vehicle Holdings Limited 8.9 2 3 CableCom Networking Holdings 5.9 Limited 3 5 Crew Clothing Company Limited 4.3 4 4 IDOX plc 3.9 5 6 CSC (World) Limited 3.4 6 7 Kaf©vend Holdings Limited 3.2 7 9 Fisher Outdoor Leisure Holdings 2.8 Limited 8 10 Valldata Group Limited 2.6 9 12 Vectura Group plc 2.2 10 15 Inspired Thinking Group Limited 2.0 Total 39.2Analysis of Total Assets Percentage of total Percentage of total assets assets 30 Sep 2011 30 Jun 2011 Unquoted investments 46 47 AIM, Listed & Collective 29 29Investments Interest Bearing 24 23 Securities Net current assets 1 1 Total cash portfolio 25 24 Total Assets 100 100

Analysis of Investment Portfolio by Sector

(excluding cash and interest bearing securities)

Percentage of total Percentage of total investments at investments at 30 Sep 2011 30 Jun 2011 Business Services 35 31 Consumer Markets 18 21 Financial Services 3 2 Healthcare & Education 11 10 IT & Media 33 36 Total 100 100Investment ActivityA total of £4.05m was invested during the period under review: four unquotedinvestments totalling £3.44m, comprising three new and one follow oninvestment, and one AIM traded investment totalling £0.61m. The three newunquoted investments were in acquisition companies led by an experiencedChairman who had previously been backed by ISIS through investment by theBaronsmead VCTs. All three investments delivered successful realisations forshareholders and the three Chairmen are now seeking new opportunities in theirchosen sectors.

After the period end a further unquoted investment of £1.35m was completed in ICCM a provider of high acuity care for home based care users.

A total of £5.57m was realised from the sale or partial sale of four unquotedinvestments and one quoted investment. These sales realised net capital profitsof £2.48m, being 1.8 times the cost of the investments.Investments madeCompany Date Cost (£'000) Escher Group Holdings plc Aug 2011 614 Independent Living Services Limited* Sep 2011 438 Arcas Investments Limited± Sep 2011 1,000 Quest Venture Partners Limited± Sep 2011 1,000 HealthTech Innovation Partners Limited± Sep 2011 1,000 Total investments 4,052*Follow on investment±Acquisition vehiclesRealisationsCompany Date Cost Proceeds Multiple* (£'000) (£'000) Alere Inc Aug 2011 157 108 0.7 Carnell Contractors Aug 2011 558 558 N/ALimited (partial loan redemption) Getting Personal Limited Jul 2011 988 1,811 ND^ MLS Limited (partial loan Sep 2011 188 188 1.0redemption) Quantix Limited Sep 2011 1,194 2,904 3.1 Total realisations 3,085 5,569

* Multiple includes interest and dividends received, loan note redemptions and partial realisations accounted for in prior periods.

^Not disclosed

Net Asset Value

The NAV per share at 31 October 2011 was 105.03p representing a decrease of 0.37p per share (0.35%) since the quarter end as a result of the decrease in the value of the Company's investments in quoted companies.

Events after the period end(to be updated)

Declaration of dividend

The Board has declared a second interim dividend in lieu of a final dividend of4.5p per share, resulting in total dividends for the year of 7.5 per share. Thedividend will be payable on 9 December to shareholders on the register as of 25November 2011. The ex-dividend date will be the 23 November 2011.

New investments

Since 30 September 2011, the Company has invested a total of £1.5m in one newunquoted and one new quoted investment. The Company has investments in 67companies, 21 unquoted and 46 quoted investments and exposure to a further 29companies through the investment in Wood Street Microcap Investment Fund.

Other than the events described above, the Board is not aware of any significant events or transactions which have occurred between 30 September 2011 and the date of publication of this statement which would have a material impact on the financial position of the Company.

Investment objective

Baronsmead VCT 3 plc is a tax efficient listed company which aims to achieve long-term investment returns for private investors.

Further information

Further information regarding the Company, including net asset values published since the end of the period and quarterly factsheets, can be found at the Company's website www.baronsmeadvct3.co.uk

Contact

For further information please contact:

Michael Probin Investor Relations Manager 020 7506 5600 michael.probin@isisep.com

XLON
Date   Source Headline
14th Aug 20245:55 pmRNSTransaction in Own Shares
7th Aug 202410:30 amRNSReplacement Net Asset Value(s)
6th Aug 20244:52 pmRNSNet Asset Value(s)
25th Jul 20245:30 pmRNSNet Asset Value(s)
1st Jul 202412:07 pmRNSTotal Voting Rights
26th Jun 20245:26 pmRNSTransaction in Own Shares
11th Jun 20247:00 amRNSHalf-yearly Report
6th Jun 20241:30 pmRNSNet Asset Value(s)
3rd Jun 202412:22 pmRNSTotal Voting Rights
24th May 20245:44 pmRNSTransaction in Own Shares
7th May 20244:00 pmRNSNet Asset Value(s)
7th May 202411:47 amRNSCompliance with Market Abuse Regulation ("MAR")
1st May 202411:11 amRNSTotal Voting Rights
29th Apr 20243:30 pmRNSNet Asset Value(s)
3rd Apr 20249:00 amRNSShare Allotment, Total Voting Rights, Offer Close
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSClose of Offer to New Applications
20th Mar 20248:02 amRNSCHANGE OF ALLOTMENT DATE & EXTENSION OF THE OFFER
19th Mar 20245:37 pmRNSClose of Offer to New Applications
18th Mar 20244:48 pmRNSDirector/PDMR Shareholding
18th Mar 20244:46 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSIntention to Utilise Over-allotment Facility
6th Mar 20243:00 pmRNSNet Asset Value(s)
6th Mar 20241:46 pmRNSResult of AGM
1st Mar 202410:34 amRNSTotal Voting Rights
15th Feb 20242:00 pmRNSAllotment of Shares and Total Voting Rights
7th Feb 202410:00 amRNSNet Asset Value(s)
2nd Feb 20242:50 pmRNSDirector/PDMR Shareholding
1st Feb 20245:12 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
30th Jan 202412:03 pmRNSDirector/PDMR Shareholding
26th Jan 20242:30 pmRNSAllotment of Shares and Total Voting Rights
24th Jan 20245:00 pmRNSNet Asset Value(s)
24th Jan 20244:00 pmRNSNet Asset Value(s)
22nd Jan 20243:00 pmRNSOffer Update Extension of Early Bird Discount Date
19th Jan 20242:35 pmRNSIssue of Supplementary Prospectus
4th Jan 20243:46 pmRNSChange of allotment date
2nd Jan 202411:00 amRNSTotal Voting Rights
22nd Dec 20237:00 amRNSAnnual Financial Report
12th Dec 20235:46 pmRNSTransaction in Own Shares
6th Dec 20231:30 pmRNSNet Asset Value(s)
24th Nov 20231:26 pmRNSPublication of a Prospectus/Offer for Subscription
22nd Nov 20237:00 amRNSCompliance with Market Abuse Regulation ("MAR")
14th Nov 202310:05 amRNSUpdate on Offer for Subscription
6th Nov 20234:00 pmRNSNet Asset Value(s)
27th Oct 20231:30 pmRNSNet Asset Value(s)
2nd Oct 20234:02 pmRNSTotal Voting Rights
28th Sep 20235:52 pmRNSTransaction in Own Shares
25th Sep 202312:28 pmRNSDirector/PDMR Shareholding
25th Sep 202312:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.